Scandion Oncology A/S: Postponement of extraordinary general meeting
We hereby announce that the planned extraordinary general meeting of Scandion Oncology A/S (the “Company”) is postponed.Following the notice on September 21, 2021 to convene for an extraordinary general meeting in the Company on October 6, 2021, shareholders representing more than 5% of the share capital have requested an additional extraordinary general meeting to be held in order to propose that the Board of Directors receive an authorization to establish a Share-Buyback program. The Board of Directors has not at present assessed whether it wants to make use of such an authorization